Kai Yamasaki

11PUBLICATIONS
27CO-AUTHORS
NanomedicineInstruments and techniquesCancer therapy (excl. chemotherapy and radiation therapy)Radiation therapyNeonatology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Mar 11, 2026
Molecular and clinical features of a Japanese medulloblastoma cohort: Subgroup-specific prognostic stratification using economical/accessible diagnostic methods.

Kohichi Go, Asako Katsuma, Ema Yoshioka

|Apr 19, 2023
Focal versus craniospinal radiation for disseminated atypical teratoid/rhabdoid tumor following favorable response to systemic therapy.

Paul D Aridgides, Anita Mahajan, Bree Eaton

|Mar 31, 2021
Thiotepa-melphalan myeloablative therapy for high-risk neuroblastoma.

Fumito Yamazaki, Kai Yamasaki, Chikako Kiyotani

|Dec 30, 2020
Rhabdoid tumor predisposition syndrome with renal tumor 10 years after brain tumor.

Hiroko Fukushima, Kai Yamasaki, Miho Sakaida

|Sep 24, 2019
Strategy to minimize radiation burden in infants and high-risk medulloblastoma using intrathecal methotrexate and high-dose chemotherapy: A prospective registry study in Japan.

Kai Yamasaki, Keiko Okada, Toshinori Soejima

|Aug 09, 2019
Double-conditioning regimen consisting of high-dose thiotepa and melphalan with autologous stem cell rescue for high-risk pediatric solid tumors: A second report.

Keiko Okada, Kai Yamasaki, Chika Nitani

Pageof 2

Frequent Collaborators

3 joint publications

Yoshiko Nakano

3 joint publications

Keiko Okada

1 joint publications

Douglas R Stewart

1 joint publications

Satoshi Yamashita